Signos raises $20M, expands Dexcom partnership for weight loss

Signos Inc. announced a $20 cardinal backing circular connected Wednesday, with backing from GV (Google Ventures), Dexcom, and Blue Cross Blue Shield of Alabama, alongside a caller organisation woody that volition marque the startup's subscription plans disposable connected Dexcom's direct-to-consumer website.

Signos was founded to amended metabolic wellness utilizing technology. The institution created an AI-powered glucose monitoring level for value absorption and became the archetypal successful its class to person FDA clearance successful 2025. The strategy uses a Dexcom biosensor to way glucose levels, past analyzes information related to eating, rest, and accent to supply personalized proposal for healthier habits.

As portion of the expanded partnership, Signos volition beryllium sold done Stelo.com, Dexcom's direct-to-consumer site. Dexcom besides participated successful the backing round. "Signos has developed a strategy that translates glucose biosensing information into actionable insights for radical focused connected value management," said Jon Coleman, Dexcom's main commercialized officer, successful a statement. "Making Signos disposable connected Stelo.com is simply a earthy adjacent step."

Among the planned uses for the caller concern is simply a build-out of predictive AI capabilities, including a meal-scoring relation that draws connected idiosyncratic individual past to measure imaginable glucose interaction earlier a idiosyncratic eats, according to CNBC.

Tenfold maturation successful some gross and the idiosyncratic basal implicit the anterior six months was cited by Fouladgar-Mercer, who stopped abbreviated of providing existent numbers. He told CNBC that "tens of thousands" of users person participated successful objective studies. The institution besides declined to stock its valuation pursuing the round.

Fouladgar-Mercer told CNBC that Signos is built to service 2 chiseled idiosyncratic types: radical already taking GLP-1 medications who privation further metabolic insight, and those pursuing value nonaccomplishment without pharmaceutical intervention. "The value absorption class is being wholly reimagined close now, and the approaches that volition endure are the ones that harvester the champion of medicine with the champion of personalized data," helium said successful a statement.

Blue Cross Blue Shield of Alabama invested done its 450 Ventures vehicle, a awesome the institution said reflects increasing involvement among wellness insurers successful metabolic wellness tools arsenic GLP-1 cause costs spot unit connected payer budgets. Signos was founded successful 2018.